ES2062050T3 - Derivados de piperazinilo. - Google Patents
Derivados de piperazinilo.Info
- Publication number
- ES2062050T3 ES2062050T3 ES89313371T ES89313371T ES2062050T3 ES 2062050 T3 ES2062050 T3 ES 2062050T3 ES 89313371 T ES89313371 T ES 89313371T ES 89313371 T ES89313371 T ES 89313371T ES 2062050 T3 ES2062050 T3 ES 2062050T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- piperazinyl
- derivatives
- sterotonin
- isomeres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
EL INVENTO SE REFIERE A NUEVOS COMPUESTOS DE FORMULA: DONDE DR1,R2,X Y "AR" SON COMO ESTAN DEFINIDOS EN LA DEMANDA 1; ASI COMO LAS SALES ACIDAS FARMACEUTICAMENTE ACEPTABLES Y LOS ISONUEROS ESTEREOS DE LO MISMO. LOS COMPUESTOS TIENEN ACTIVIDAD ESTEROMINA CENTRAL CON PREFERENCIA PARA LOS RECEPTORES DE SEROTONINA S-HT1A, QUE SON INDICADOS EN EL TRATAMIENTO DE DESORDENES DEL CNS, INCLUYENDO ANSIEDAD, DEPRESION Y AGRESIVIDAD, O EN ENFERMEDADES RELACIONADAS CON LOS SISTEMAS CARDIOBASCULAR, GASTROINTESTINAL Y RENAL. TAMBIEN SE DESCRIBEN METODOS DE PREPARACION DE DICHOS COMPUESTOS, Y COMPOSICIONES FARMACEUTICAS CONTENIENDOLOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888830312A GB8830312D0 (en) | 1988-12-28 | 1988-12-28 | Heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2062050T3 true ES2062050T3 (es) | 1994-12-16 |
Family
ID=10649223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89313371T Expired - Lifetime ES2062050T3 (es) | 1988-12-28 | 1989-12-20 | Derivados de piperazinilo. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5002948A (es) |
EP (1) | EP0376607B1 (es) |
JP (1) | JP2895121B2 (es) |
AT (1) | ATE102184T1 (es) |
AU (1) | AU637991B2 (es) |
CA (1) | CA2006356C (es) |
DE (1) | DE68913487T2 (es) |
DK (1) | DK169266B1 (es) |
ES (1) | ES2062050T3 (es) |
FI (1) | FI93005C (es) |
GB (1) | GB8830312D0 (es) |
IE (1) | IE62668B1 (es) |
IL (1) | IL92990A (es) |
NO (1) | NO174772C (es) |
NZ (1) | NZ231855A (es) |
PT (1) | PT92728B (es) |
ZA (1) | ZA899960B (es) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3923045A1 (de) * | 1989-07-13 | 1991-01-17 | Merck Patent Gmbh | Indolderivate |
EP0465254B1 (en) * | 1990-07-06 | 1996-11-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused thiophene compounds and uses thereof |
US5643784A (en) * | 1990-12-04 | 1997-07-01 | H, Lundbeck A/S | Indan derivatives |
FR2670491B1 (fr) * | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
DE4101686A1 (de) * | 1991-01-22 | 1992-07-23 | Merck Patent Gmbh | Indolderivate |
NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
DE4127849A1 (de) * | 1991-08-22 | 1993-02-25 | Merck Patent Gmbh | Benzodioxanderivate |
CA2084531A1 (en) * | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
ES2050623B1 (es) * | 1992-11-06 | 1994-12-16 | Merck Patent Gmbh | Derivados de 1,4-benzodioxano. |
DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
AU5715494A (en) * | 1992-12-21 | 1994-07-19 | Taisho Pharmaceutical Co., Ltd. | N-substituted indole derivative |
GB9305623D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
RU2118322C1 (ru) * | 1993-07-05 | 1998-08-27 | Дюфар Интернэшнл Рисерч Б.В. | 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли |
DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
US5552402A (en) * | 1994-05-19 | 1996-09-03 | Merck, Sharp & Dohme Ltd. | Five-membered heteroaromatic compounds as 5-HT receptor agonists |
DE19512639A1 (de) | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
CA2222532A1 (en) * | 1995-05-31 | 1996-12-05 | Nisshin Flour Milling Co., Ltd. | Indazole derivatives having monocyclic amine |
JPH09124643A (ja) * | 1995-08-14 | 1997-05-13 | Bristol Myers Squibb Co | 抗うつ作用を有する1−アリールアルキル−4−(アルコキシピリジニル)−又は4−(アルコキシピリミジニル)ピペラジン誘導体 |
WO1998008816A1 (fr) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Derives d'indoxyle et psychotropes |
AR013206A1 (es) * | 1997-07-25 | 2000-12-13 | Lundbeck & Co As H | Derivados indol y 2,3-dihidroindol, composiciones farmaceuticas que contienen estos compuestos y el uso de dichos compuestos para la preparacion de un medicamento para el tratamiento de desordenes sensibles a la inhibicion de la reabsorcion de serotonina y antagonismo de receptores 5-ht1a. |
DE69819173T2 (de) * | 1997-07-25 | 2004-04-15 | H. Lundbeck A/S | Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung |
ATE223379T1 (de) * | 1998-04-08 | 2002-09-15 | Wyeth Corp | N-aryloxyethylaminderivate zur behandlung der depression |
AR022303A1 (es) | 1999-01-22 | 2002-09-04 | Lundbeck & Co As H | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion |
SK287018B6 (sk) * | 1999-08-23 | 2009-09-07 | Solvay Pharmaceuticals B. V. | Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie |
HUP0203645A3 (en) * | 1999-12-30 | 2004-01-28 | Lundbeck & Co As H | Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use |
AR027134A1 (es) * | 1999-12-30 | 2003-03-12 | Lundbeck & Co As H | Derivados de indol. |
EP1246816B1 (en) * | 1999-12-30 | 2004-03-17 | H. Lundbeck A/S | Substituted phenyl-piperazine derivatives, their preparation and use |
US6897231B2 (en) * | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
US7211594B2 (en) * | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
AR032712A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
US7041683B2 (en) | 2001-04-24 | 2006-05-09 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan |
US6559169B2 (en) | 2001-04-24 | 2003-05-06 | Wyeth | Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-benzodioxan |
ATE424825T1 (de) | 2001-07-20 | 2009-03-15 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
KR20050085472A (ko) | 2002-12-10 | 2005-08-29 | 메르크 파텐트 게엠베하 | 인돌 유도체 및 5-ht 리간드로서의 이의 용도 |
US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
DE10326940A1 (de) * | 2003-06-16 | 2005-01-05 | Merck Patent Gmbh | Indol-Derivate |
DE10326939A1 (de) * | 2003-06-16 | 2005-01-05 | Merck Patent Gmbh | Indol-Derivate |
WO2005102342A1 (en) * | 2004-04-22 | 2005-11-03 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for the treatment of sexual disorders ii |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
EP1776339B1 (en) * | 2004-05-11 | 2009-07-01 | EGIS Gyógyszergyár Nyrt | 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
ATE382045T1 (de) * | 2004-05-11 | 2008-01-15 | Egis Gyogyszergyar Nyrt | Indol-2-onderivate zur behandlung von erkrankungen des zentralen nervensystems, erkrankungen des magen-darm-trakts und herzkreislauferkankungen |
HUP0400953A3 (en) * | 2004-05-11 | 2008-02-28 | Egis Gyogyszergyar Nyilvanosan | Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use |
NZ551542A (en) * | 2004-05-11 | 2010-06-25 | Egis Gyogyszergyar Nyrt | Piperazine derivatives of alkyl oxindoles |
JP2007537225A (ja) * | 2004-05-11 | 2007-12-20 | エギシュ ヂョヂセルヂャール エンニュ・エル・テー | 5−ht7活性剤としてのアルキルオキシインドールのピリジン誘導体 |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
EP1789048A1 (en) * | 2004-09-03 | 2007-05-30 | Boehringer Ingelheim International GmbH | Method for the treatment of attention deficit hyperactivity disorder |
CA2587940A1 (en) * | 2004-12-07 | 2006-06-15 | Solvay Pharmaceuticals B.V. | Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
US7371769B2 (en) | 2004-12-07 | 2008-05-13 | Solvay Pharmaceuticals B.V. | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
US20070072870A2 (en) | 2004-12-08 | 2007-03-29 | Solvay Pharmeceuticals B.V. | Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
JP2008531714A (ja) * | 2005-03-04 | 2008-08-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 不安障害の治療用及び/又は予防用の医薬組成物 |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
US20060211685A1 (en) * | 2005-03-04 | 2006-09-21 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
US20070004777A1 (en) * | 2005-03-23 | 2007-01-04 | Bhagwat Shripad S | Methods for treating or preventing acute myelogenous leukemia |
WO2006119884A2 (en) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug abuse with flibanserin |
JP2008540672A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 病状に起因する性的機能不全の治療方法 |
EP1888071A1 (en) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Method for the treatment of drug-induced sexual dysfunction |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
NZ573382A (en) * | 2006-05-09 | 2012-02-24 | Boehringer Ingelheim Int | Use of flibanserin for the treatment of post-menopausal sexual desire disorders |
WO2008000760A1 (en) * | 2006-06-30 | 2008-01-03 | Boehringer Ingelheim International Gmbh | Flibanserin for the treatment of urinary incontinence and related diseases |
EP2043648A1 (en) * | 2006-07-14 | 2009-04-08 | Boehringer Ingelheim International GmbH | Use of flibanserin for the treatment of sexual disorders in females |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
EP2054041A2 (en) | 2006-08-14 | 2009-05-06 | Boehringer Ingelheim International GmbH | Formulations of flibanserin and method for manufacturing the same |
AR062321A1 (es) | 2006-08-25 | 2008-10-29 | Boehringer Ingelheim Int | Sistema de liberacion controlada y metodo para fabricarlo |
CL2008002693A1 (es) * | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
US8742100B2 (en) | 2009-07-30 | 2014-06-03 | National University Of Singapore | Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity |
WO2011019738A1 (en) * | 2009-08-10 | 2011-02-17 | Galenea Corporation | Compounds and methods of use thereof |
CN102993186B (zh) * | 2012-12-20 | 2015-11-18 | 北京海步国际医药科技发展有限公司 | 一种新型的哌嗪衍生物 |
EP3027607B1 (en) | 2013-07-29 | 2020-08-26 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
WO2015090235A1 (en) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use thereof |
CN106065018B (zh) * | 2015-04-23 | 2020-04-21 | 广东东阳光药业有限公司 | 取代的吲哚化合物及其使用方法和用途 |
US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB944443A (es) * | 1959-09-25 | 1900-01-01 | ||
GB1075156A (en) * | 1963-08-27 | 1967-07-12 | Luso Farmaco Inst | Substituted piperazines |
MC614A1 (fr) * | 1966-04-21 | 1967-05-31 | Cerm Cent Europ Rech Mauvernay | Nouveau composé analgésique et anti-inflammatoire. |
US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
US3678059A (en) * | 1969-10-07 | 1972-07-18 | Ciba Geigy Corp | 3-aminoalkylidene-indazoles |
US3900495A (en) * | 1971-05-27 | 1975-08-19 | American Cyanamid Co | Intermediate indolines |
US3751417A (en) * | 1971-08-12 | 1973-08-07 | American Cyanamid Co | 1-acyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)indolines |
ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
FR2475898A1 (fr) * | 1980-02-14 | 1981-08-21 | Andre Buzas | Medicament analgesique contenant de la 1-(3'-benzofuryl)-4-benzylpiperazine et son procede de preparation |
US4452799A (en) * | 1981-12-23 | 1984-06-05 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
US4710573A (en) * | 1983-08-22 | 1987-12-01 | Hoechst Roussel Pharmaceuticals, Inc. | 3-(piperidinyl)-and 3-(pyrrolidinyl)-1H-indazoles |
EP0190472B1 (en) * | 1984-12-21 | 1989-07-12 | Duphar International Research B.V | New pharmaceutical compositions having anti-psychotic properties |
DE3604949A1 (de) * | 1986-02-17 | 1987-08-20 | Merck Patent Gmbh | Hydroxyindolester |
US4831156A (en) * | 1987-09-30 | 1989-05-16 | The University Of Tennessee Research Corp. | 3-substituted 2-alkyl indole derivatives |
US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
DE3923045A1 (de) * | 1989-07-13 | 1991-01-17 | Merck Patent Gmbh | Indolderivate |
-
1988
- 1988-12-28 GB GB888830312A patent/GB8830312D0/en active Pending
-
1989
- 1989-12-12 IE IE397689A patent/IE62668B1/en not_active IP Right Cessation
- 1989-12-19 NZ NZ231855A patent/NZ231855A/en unknown
- 1989-12-19 DK DK645689A patent/DK169266B1/da not_active IP Right Cessation
- 1989-12-20 ES ES89313371T patent/ES2062050T3/es not_active Expired - Lifetime
- 1989-12-20 DE DE68913487T patent/DE68913487T2/de not_active Expired - Lifetime
- 1989-12-20 AT AT89313371T patent/ATE102184T1/de not_active IP Right Cessation
- 1989-12-20 EP EP89313371A patent/EP0376607B1/en not_active Expired - Lifetime
- 1989-12-21 CA CA002006356A patent/CA2006356C/en not_active Expired - Lifetime
- 1989-12-22 AU AU47198/89A patent/AU637991B2/en not_active Ceased
- 1989-12-26 US US07/456,938 patent/US5002948A/en not_active Expired - Lifetime
- 1989-12-27 JP JP1336755A patent/JP2895121B2/ja not_active Expired - Fee Related
- 1989-12-27 NO NO895281A patent/NO174772C/no not_active IP Right Cessation
- 1989-12-27 PT PT92728A patent/PT92728B/pt not_active IP Right Cessation
- 1989-12-28 FI FI896300A patent/FI93005C/fi active IP Right Grant
- 1989-12-28 ZA ZA899960A patent/ZA899960B/xx unknown
-
1990
- 1990-01-07 IL IL9299090A patent/IL92990A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE62668B1 (en) | 1995-02-22 |
PT92728B (pt) | 1995-12-29 |
DK645689D0 (da) | 1989-12-19 |
AU637991B2 (en) | 1993-06-17 |
DK169266B1 (da) | 1994-09-26 |
EP0376607B1 (en) | 1994-03-02 |
IL92990A0 (en) | 1990-09-17 |
FI896300A0 (fi) | 1989-12-28 |
NO174772B (no) | 1994-03-28 |
NO895281D0 (no) | 1989-12-27 |
NO174772C (no) | 1994-07-06 |
EP0376607A1 (en) | 1990-07-04 |
CA2006356C (en) | 1999-09-14 |
CA2006356A1 (en) | 1990-06-28 |
JPH02225460A (ja) | 1990-09-07 |
GB8830312D0 (en) | 1989-02-22 |
JP2895121B2 (ja) | 1999-05-24 |
DK645689A (da) | 1990-06-29 |
NZ231855A (en) | 1992-02-25 |
DE68913487T2 (de) | 1994-08-04 |
IE893976L (en) | 1990-06-13 |
PT92728A (pt) | 1990-06-29 |
FI93005B (fi) | 1994-10-31 |
FI93005C (fi) | 1995-02-10 |
ZA899960B (en) | 1990-11-28 |
DE68913487D1 (de) | 1994-04-07 |
ATE102184T1 (de) | 1994-03-15 |
NO895281L (no) | 1990-06-29 |
AU4719889A (en) | 1990-07-05 |
US5002948A (en) | 1991-03-26 |
IL92990A (en) | 1995-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2062050T3 (es) | Derivados de piperazinilo. | |
NL300006I2 (nl) | Imidazolylalkeenzuurderivaten. | |
DE3880396D1 (de) | Zur behandlung von neurodegenerativen erkrankungen verwendbare kynurensaeurederivate. | |
ES2036926A1 (es) | "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina". | |
DE68906609T2 (de) | Dopamin-vorlaeufer. | |
NO173499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinforbindelser | |
DE3485419D1 (de) | Glyzerinderivate. | |
NO164474C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater. | |
FI933652A (fi) | Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler | |
SE8305362D0 (sv) | Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 376607 Country of ref document: ES |